Xiaoqinglong granules as add-on therapy for asthma: latent class analysis of symptom predictors of response.

Evid Based Complement Alternat Med · 2013 · PMC3574648 · PMID 23431348

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

For example, XQLD appears to inhibit mast cell degranulation [ 26 ] and influence CD4(+) T cells, which may be significant in developing its use in the treatment of IgE-mediated allergic asthma [ 16 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.